Halozyme
HALO
423 hedge funds and large institutions have $7.26B invested in Halozyme in 2022 Q4 according to their latest regulatory filings, with 90 funds opening new positions, 111 increasing their positions, 178 reducing their positions, and 20 closing their positions.
350% more first-time investments, than exits
New positions opened: 90 | Existing positions closed: 20
173% more call options, than puts
Call options by funds: $44M | Put options by funds: $16.1M
157% more funds holding in top 10
Funds holding in top 10: 7 → 18 (+11)
39% more capital invested
Capital invested by funds: $5.22B → $7.26B (+$2.04B)
18% more funds holding
Funds holding: 357 → 423 (+66)
0.53% less ownership
Funds ownership: 96.11% → 95.58% (-0.53%)
38% less repeat investments, than reductions
Existing positions increased: 111 | Existing positions reduced: 178
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$51.9M |
| 2 |
Two Sigma Investments
New York
|
+$22.7M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$18.8M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$16.7M |
| 5 |
Two Sigma Advisers
New York
|
+$13.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$47.2M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
-$37.6M |
| 3 |
William Blair Investment Management
Chicago,
Illinois
|
-$37.4M |
| 4 |
JP Morgan Chase
New York
|
-$36.1M |
| 5 |
State Street
Boston,
Massachusetts
|
-$23.5M |
HALO Hedge Fund Activity: Q4 2022 in Review
423 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Halozyme (HALO) for Q4 2022, worth a combined $7.26B — up 39% from $5.22B a quarter earlier.
Buyers outnumbered sellers: 90 funds opened new HALO positions and 20 closed out — a net gain of 70 holders — while 111 added to existing stakes and 178 trimmed.
The largest buyer was Artisan Partners, adding an estimated $51.9M. The largest seller was Millennium Management, cutting an estimated $47.2M.
- 423 institutional investors held Halozyme (HALO) as of Q4 2022, up from 357 in Q3 2022.
- Funds reported $7.26B of Halozyme stock for Q4 2022, up 39% quarter-over-quarter.
- 90 funds opened new Halozyme positions in Q4 2022 and 20 closed out, a net change of +70 holders.
- The largest Halozyme buyer in Q4 2022 was Artisan Partners, an estimated $51.9M added.
- The largest Halozyme seller in Q4 2022 was Millennium Management, an estimated $47.2M sold.
Based on aggregated 13F filings for Q4 2022.